Zobrazeno 1 - 10
of 31
pro vyhledávání: ''
Autor:
Garrick Kassab, José Baselga, Alvaro Moreno-Aspitia, Otto Metzger Filho, Richard D. Gelber, David W. Hillman, Kamal S Saini, Christine Campbell, Ann E. McCullough, Larissa A. Korde, Antonio C. Wolff, Masakazu Toi, Kathleen I. Pritchard, Miguel Izquierdo, Zeba Aziz, Daniela Dornelles Rosa, Frances M. Boyle, Ian E. Smith, Celine Schurmans, Georgia Demetriou, István Láng, Michael Untch, Binghe Xu, Zhimin Shao, Eileen Holmes, Evandro de Azambuja, Carlos Barrios, Eleanor McFadden, Martin Andersson, Martine Piccart-Gebhart, Debora Fumagalli, Sung Hoon Sim, Robin McConnell, Christian Jackisch, Ajay O. Mehta, Sarra El-Abed, Vicki Paterson, Emma Paterson, Florentine Hilbers, Michael S. Ewer, Vasiliki Balta, Sebastien Guillaume
Publikováno v:
Eur J Cancer
Aim To present the pre-specified analyses of >5-years follow-up of the Phase III ALTTO trial. Patients and methods 8381 patients with stage I-III HER2 positive breast cancer randomised to chemotherapy plus 1-year of trastuzumab (T), oral lapatinib (L
Autor:
Younsoo Kim, Xavier Pivot, Igor Bondarenko, Diana Lüftner, Giuseppe Curigliano, Chul Kim, Javier Cortes, Ye Chan Yoon, Gary H. Lyman, Mark D. Pegram
Publikováno v:
European journal of cancer (Oxford, England : 1990). 120
Background We assessed long-term cardiac safety and efficacy in patients with human epidermal growth factor receptor 2–positive early breast cancer treated with a trastuzumab biosimilar (SB3) or its reference product, trastuzumab (TRZ), in a phase
Autor:
C. Goessl, Nadine Tung, Suzette Delaloge, Wendy Bannister, Elżbieta Senkus, Binghe Xu, Arnold Degboe, Pierfranco Conte, Norikazu Masuda, Robert Hettle, Seock Ah Im, Kathryn J. Ruddy, Susan M. Domchek, Anne C Armstrong, Wei Li, Mark E. Robson
Publikováno v:
Eur J Cancer
Background The phase III OlympiAD study (NCT02000622) showed a statistically significant progression-free survival benefit with olaparib versus chemotherapy treatment of physician's choice (TPC) in patients with a germline BRCA mutation and human epi
Publikováno v:
European journal of cancer (Oxford, England : 1990). 120
Purpose Tumour-infiltrating lymphocyte (TIL) detection by histology is associated with outcomes in breast cancer; nevertheless, analysis standardisation is difficult. We determined whether transcriptomic data could generate a genomic signature that e
Autor:
Tomasz Sarosiek, Yaroslav Shparyk, Vladimir Moiseyenko, Seock Ah Im, Maximino De Guzman Bello, Xavier Pivot, Vladimir Semiglazov, Jae Yun Lim, Marek Z. Wojtukiewicz, M. Dvorkin, J.-H. Ahn, Y. Lee, Igor Bondarenko, Ekaterina Trishkina, Zbigniew Nowecki, Sanjoy Chatterjee
Publikováno v:
European journal of cancer (Oxford, England : 1990). 93
Background The equivalent efficacy between SB3, a proposed trastuzumab biosimilar, and the trastuzumab reference product (TRZ) in terms of the breast pathologic complete response rate after neoadjuvant therapy in patients with early or locally advanc
Autor:
Paul M. Walsh, Annalisa Trama, Milena Sant, Laura Botta, Rafael Marcos-Gragera, Kaire Innos, Tom Børge Johannesen, Pamela Minicozzi, Silvia Rossi, María José Sánchez, Nadya Dimitrova
Publikováno v:
European journal of cancer (Oxford, England : 1990). 93
Background Cancer survival has persistently been shown to be worse for Eastern European and UK/Ireland patients than those of other European regions. This is often attributed to later stage at diagnosis. However, few stage-specific survival compariso
Autor:
Serena Catania, M. Podda, Maria Luisa Carcangiu, Massimiliano Gennaro, Lorenza Gandola, Monica Terenziani, Maura Massimino, A. Di Russo, D. Magazzù, E. Schiavello, P. Valagussa, Cristina Meazza, Giuseppe Capri
Publikováno v:
European journal of cancer (Oxford, England : 1990). 51(13)
Rationale The risk of women developing a breast cancer (BC) after receiving chest radiotherapy for paediatric cancers and Hodgkin lymphomas is well established. The aim of this study was to assess these patients’ clinical characteristics and clinic
Autor:
Vriens, B.E., Aarts, M.J., Vries, B. de, Gastel, S.M. van, Wals, J., Smilde, T.J., Warmerdam, L.J. van, Boer, M. de, Spronsen, D.J. van, Borm, G.F., Tjan-Heijnen, V.C., Stienen, J.J.C., Hermens, R.P.M.G., Wennekes, L., Schans, S.A. van de, Dekker, H.M., Blijlevens, N.M.A., Maazen, R.W.M. van der, Adang, E.M.M., Krieken, J.H.J.M. van, Ottevanger, P.B.
Publikováno v:
European Journal of Cancer, 49, 15, pp. 3102-10
European Journal of Cancer, 49, 3102-10
European Journal of Cancer, 49(15), 3102-3110. ELSEVIER SCI LTD
European Journal of Cancer, 49, 3102-10
European Journal of Cancer, 49(15), 3102-3110. ELSEVIER SCI LTD
Contains fulltext : 127295.pdf (Publisher’s version ) (Closed access) Abstract BACKGROUND: This study was designed to determine whether delivering neo-adjuvant chemotherapy at a higher dose in a shorter period of time improves outcome of breast can
Autor:
Emilie Lanoy, Nicolas Mounier, Dominique Costagliola, Isabelle Heard, Christine Katlama, Jean-Philippe Spano
Publikováno v:
European journal of cancer (Oxford, England : 1990). 48(18)
Background The cross-sectional ONCOVIH study prospectively enrolled HIV-infected adults and children with newly diagnosed malignancies in France in 2006. Method We report the characteristics HIV-infected patients with breast cancer from the ONCOVIH s
Autor:
Garcia-Etienne, Carlos A., Tomatis, Mariano, Heil, Joerg, Friedrichs, Kay, Kreienberg, Rolf, Denk, Andreas, Kiechle, Marion, Lorenz-Salehi, Fatemeh, Kimmig, Rainer, Emons, Günter, Danaei, Mahmoud, Heyl, Volker, Heindrichs, Uwe, Rageth, Christoph J., Janni, Wolfgang, Marotti, Lorenza, Del Turco, Marco Rosselli, Ponti, Antonio, Cataliotti, Luigi, Cretella, Elisabetta, Van Dam, Peter, Emons, Adelgund, Gyr, Thomas, Hils, Rita, Kern, Peter, Koehler, Uwe, Kuemmel, Sherko, Liedtke, Doris, Luini, Alberto, Moebus, Volker, Neumann, Monika, Paepke, Stefan, Pagani, Olivia, Pavesi, Lorenzo, Sarlos, Dimitri, Schlotfeldt, Tim, Sohn, Cristof, Spelsberg, Angela, Staelens, Gracienne, Taffurelli, Mario, Tinterri, Corrado, Vergin, Iris B., Zemmler, Thomas, Wagner, Dominik, Turco, Marco Rosselli del
Publikováno v:
European journal of cancer (Oxford, England : 1990). 48(13)
Recent single-institution reports have shown increased mastectomy rates during the last decade. Further studies aiming to determine if these reports could be reflecting a national trend in the United States of America (US) have shown conflicting resu